23 related articles for article (PubMed ID: 21284259)
1. Covalently tethering siRNA to hydrogels for localized, controlled release and gene silencing.
Nguyen MK; Huynh CT; Gilewski A; Wilner SE; Maier KE; Kwon N; Levy M; Alsberg E
Sci Adv; 2019 Aug; 5(8):eaax0801. PubMed ID: 31489374
[TBL] [Abstract][Full Text] [Related]
2. Oxime ether lipids containing hydroxylated head groups are more superior siRNA delivery agents than their nonhydroxylated counterparts.
Gupta K; Mattingly SJ; Knipp RJ; Afonin KA; Viard M; Bergman JT; Stepler M; Nantz MH; Puri A; Shapiro BA
Nanomedicine (Lond); 2015; 10(18):2805-18. PubMed ID: 26107486
[TBL] [Abstract][Full Text] [Related]
3. Well-defined degradable cationic polylactide as nanocarrier for the delivery of siRNA to silence angiogenesis in prostate cancer.
Chen CK; Law WC; Aalinkeel R; Nair B; Kopwitthaya A; Mahajan SD; Reynolds JL; Zou J; Schwartz SA; Prasad PN; Cheng C
Adv Healthc Mater; 2012 Nov; 1(6):751-61. PubMed ID: 23184827
[TBL] [Abstract][Full Text] [Related]
4. Alginate-Chitosan Hydrogels Containing shRNA Plasmid for Inhibition of CTNNB1 Expression in Breast Cancer Cells.
Cömez B; Özbaş S
Gels; 2023 Jul; 9(7):. PubMed ID: 37504420
[TBL] [Abstract][Full Text] [Related]
5. Induced apoptosis in human prostate cancer cells by blocking of vascular endothelial growth factor by siRNA.
Deezagi A; Ansari-Majd S; Vaseli-Hagh N
Clin Transl Oncol; 2012 Oct; 14(10):791-9. PubMed ID: 22855159
[TBL] [Abstract][Full Text] [Related]
6. Nucleic acid delivery with chitosan hydroxybenzotriazole.
Opanasopit P; Techaarpornkul S; Rojanarata T; Ngawhirunpat T; Ruktanonchai U
Oligonucleotides; 2010 Jun; 20(3):127-36. PubMed ID: 20420543
[TBL] [Abstract][Full Text] [Related]
7. Small interfering RNA (siRNA) targeting VEGF effectively inhibits ocular neovascularization in a mouse model.
Reich SJ; Fosnot J; Kuroki A; Tang W; Yang X; Maguire AM; Bennett J; Tolentino MJ
Mol Vis; 2003 May; 9():210-6. PubMed ID: 12789138
[TBL] [Abstract][Full Text] [Related]
8. Chitosan/short hairpin RNA complexes for vascular endothelial growth factor suppression invasive breast carcinoma.
Salva E; Kabasakal L; Eren F; Cakalağaoğlu F; Ozkan N; Akbuğa J
Oligonucleotides; 2010 Aug; 20(4):183-90. PubMed ID: 20707740
[TBL] [Abstract][Full Text] [Related]
9. [Vascular endothelial growth factor shRNA mediated by pEGFP-H1 vector plasmid effectively inhibits glioma proliferation: an experimental study].
Jiang XB; Zhao HY; Zhou F; Liu RE; Zhang FC; Zhao JS
Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(8):547-50. PubMed ID: 15949336
[TBL] [Abstract][Full Text] [Related]
10. [Effect of siRNA transfection targeting VEGF gene on proliferation and apoptosis of human breast cancer cells].
Zhang X; Xu WH; Ge YL; Hou L; Li Q
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Jan; 23(1):14-7. PubMed ID: 17210097
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of VEGF expression in A431 and MDA-MB-231 tumour cells by cationic lipid-mediated siRNA delivery.
Briane D; Slimani H; Tagounits A; Naejus R; Haddad O; Coudert R; Charnaux N; Cao A
J Drug Target; 2012 May; 20(4):347-54. PubMed ID: 22475204
[TBL] [Abstract][Full Text] [Related]
12. In vitro silencing effect of chitosan nanoplexes containing siRNA expressing vector targeting VEGF in breast cancer cell lines.
Salva E; Akbuğa J
Pharmazie; 2010 Dec; 65(12):896-902. PubMed ID: 21284259
[TBL] [Abstract][Full Text] [Related]
13. Chitosan as a carrier for targeted delivery of small interfering RNA.
Rudzinski WE; Aminabhavi TM
Int J Pharm; 2010 Oct; 399(1-2):1-11. PubMed ID: 20732398
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
